Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...
CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and anticipated ...
Zacks Investment Research on MSN
CRISPR Therapeutics (CRSP) is considered a good investment by brokers: Is that true?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...
A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act ...
Both biotechs are a bit risky, but could benefit from clinical progress this year -- and the upside would be huge. CRISPR has ...
Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.
Health and Me on MSN
Can CRISPR cure HIV? Scientists say virus removed from cells in new research
Scientists are testing CRISPR gene editing as a potential HIV cure after successfully removing the virus from infected cells ...
A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...
The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...
A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...
Scientists have used CRISPR to give the goldenberry a modern makeover, shrinking the plant by about a third and making it ...
The study used large-scale CRISPR gene-editing technology to systematically determine which genes are required as embryonic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback